retatrutide molecular structure RCSB PDB Retatrutide | GLP-1R/GIPR/GCGR ligand |

Medically supervised weight loss means we are with you every step of the way

Chen X, Fu J, Zhou F, Yang Q, Wang J, Feng H, et al

GLP-1 Access, MariTide Data, and the Oprah Effect on Obesity Care This week on On The Pen , we break down a rare FDA walk-back on GLP-1 safety labeling, major pharma signals coming out of JPM 2026, and the growing tension between patient access and legislative efforts that could restrict compounding

Liraglutide results in two placebo-controlled studies were similar with a systolic BP change of 5.6 mmHg (95% CI 5.8, 5.4) and diastolic BP change of 4.5 mmHg (95% CI 4.7, 4.3)

BMI 30 (or 27 with comorbidity)

Utilizing its proprietary Synthetic Nanodisc technology platform, DIMA Biotechnology has developed the full-length bioactive human GLP1R protein